Literature, news and videos pertinent to
The Kevin M. Hanlon
Clinical Trials Program

National Lung Screening Trial Results Highlight Importance of Lifelong Follow-up
By The ASCO Post Staff
October 10, 2022 - Supplement: Conference Highlights IASLC 2022

Screening for Lung Cancer with Low Dose Computed Tomography (LDCT)—CMS.gov Centers for Medicare & Medicaid Services

INHERIT EGFR - Studying Germline EGFR Mutations (INHERIT) —ClinicalTrials.gov

powered by Surfing Waves

The Kevin M. Hanlon Clinical Trials Program is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.

For more information about this special program, please click on...

  1. Main
  2. About
  3. Photos
  4. Inspiration
  5. Memories

Donate

We also accept PayPal™

paypal.me/ICANadvocacy


Guidestar Platinum Seal of Transparency 2021

Federal Tax I.D.: EIN 86-0818253